GABA Receptor Activators
SEE ALSO...
Items 21 to 30 of 31 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DS2 | 374084-31-8 | sc-294421 sc-294421A | 10 mg 25 mg | $510.00 $1122.00 | ||
DS2 acts as a GABA receptor modulator, characterized by its unique binding affinity for specific receptor subtypes. This compound engages in intricate hydrogen bonding and hydrophobic interactions, which contribute to its selective receptor activation. The reaction kinetics of DS2 reveal a delayed onset, allowing for prolonged receptor engagement. Its structural conformation promotes distinct allosteric effects, influencing neurotransmitter release and synaptic plasticity. | ||||||
AA 29504 | 945828-50-2 | sc-361096 sc-361096A | 5 mg 25 mg | $85.00 $357.00 | ||
AA 29504 functions as a GABA receptor modulator, distinguished by its selective interaction with various receptor isoforms. Its molecular structure facilitates unique electrostatic interactions and conformational changes, enhancing receptor sensitivity. The compound exhibits rapid kinetics, leading to swift receptor activation and subsequent downstream signaling. Additionally, AA 29504's ability to stabilize receptor complexes may influence synaptic dynamics and neuronal excitability, showcasing its intricate role in neurotransmission. | ||||||
(S)-Baclofen | 66514-99-6 | sc-396081 sc-396081A sc-396081B sc-396081C | 10 mg 25 mg 50 mg 100 mg | $290.00 $540.00 $970.00 $2000.00 | ||
(S)-Baclofen acts as a GABA receptor agonist, characterized by its stereospecific binding to GABA-B receptors. This compound induces allosteric modulation, promoting receptor conformational shifts that enhance inhibitory neurotransmission. Its unique hydrophilic properties facilitate solubility in biological systems, allowing for efficient receptor engagement. The compound's kinetic profile reveals a notable affinity for receptor sites, influencing synaptic plasticity and neuronal signaling pathways. | ||||||
Chlormezanone | 80-77-3 | sc-203887 | 1 g | $67.00 | ||
Chlormezanone functions as a GABA receptor modulator, exhibiting a distinctive interaction with the GABA-A receptor subtype. Its molecular structure allows for selective binding, leading to enhanced chloride ion influx and subsequent hyperpolarization of neuronal membranes. This compound demonstrates unique reaction kinetics, with a rapid onset of action that influences synaptic transmission dynamics. Additionally, its lipophilic characteristics contribute to its ability to traverse cellular membranes, facilitating effective receptor engagement. | ||||||
7-Chloro-1-methyl-5-phenyl-[1,2,4]triazolo[4,3-a]quinolin-4-amine | 448950-89-8 | sc-396449 | 5 mg | $380.00 | ||
7-Chloro-1-methyl-5-phenyl-[1,2,4]triazolo[4,3-a]quinolin-4-amine exhibits intriguing interactions with GABA receptors, acting as a selective modulator. Its unique triazole and quinoline framework allows for specific hydrogen bonding and π-π stacking with receptor residues, enhancing receptor affinity. This compound influences allosteric sites, leading to altered ion channel kinetics and modulating synaptic transmission. Its distinct electronic properties may also affect receptor conformational stability, impacting neuronal signaling pathways. | ||||||
Bretazenil | 84379-13-5 | sc-252512 | 5 mg | $150.00 | ||
Bretazenil is a selective GABA receptor modulator characterized by its unique binding profile. Its structural features facilitate specific interactions with the receptor's allosteric sites, promoting conformational changes that enhance receptor activity. The compound's ability to stabilize receptor states influences chloride ion flux, thereby modulating synaptic inhibition. Additionally, its distinct electronic characteristics may alter the dynamics of neurotransmitter release, impacting overall neuronal excitability. | ||||||
Progabide | 62666-20-0 | sc-476638A sc-476638 | 5 mg 100 mg | $100.00 $380.00 | ||
Progabide functions as a GABA receptor modulator, characterized by its ability to selectively engage with various receptor isoforms. Its unique molecular architecture facilitates specific interactions at the receptor interface, promoting distinct conformational changes. This compound influences neurotransmission by modulating the kinetics of GABA binding, thereby affecting downstream signaling pathways. Additionally, its solubility and stability profiles may play a role in its interaction dynamics within neural environments. | ||||||
Safranal | 116-26-7 | sc-472985 sc-472985A sc-472985C sc-472985B sc-472985D | 5 g 10 g 25 g 50 g 100 g | $153.00 $245.00 $428.00 $673.00 $1183.00 | 1 | |
Safranal acts as a GABA receptor modulator, exhibiting a unique affinity for specific receptor subtypes. Its molecular structure allows for intricate interactions with the receptor's binding sites, leading to enhanced allosteric modulation. This compound influences the kinetics of GABAergic signaling by altering the receptor's conformational dynamics, which can affect ion channel permeability. Furthermore, its distinct physicochemical properties may contribute to its role in regulating neuronal excitability and synaptic transmission. | ||||||
1-Methyl-4-imidazoleacetic acid hydrochloride | 35454-39-8 | sc-222712 sc-222712A | 10 mg 250 mg | $61.00 $612.00 | ||
1-Methyl-4-imidazoleacetic acid hydrochloride acts as a GABA receptor modulator, exhibiting a unique ability to stabilize receptor conformations through specific hydrogen bonding and electrostatic interactions. Its structural features allow for selective binding to receptor subtypes, influencing ion channel dynamics and altering synaptic transmission. The compound's solubility characteristics enhance its interaction with lipid membranes, potentially affecting membrane fluidity and receptor accessibility. | ||||||
Baclofen-d4 | 1189938-30-4 | sc-217694 sc-217694A | 1 mg 10 mg | $503.00 $3719.00 | ||
Baclofen-d4 functions as a GABA receptor modulator, characterized by its isotopic labeling that allows for precise tracking in biochemical studies. Its unique deuterated structure influences kinetic properties, enhancing stability during metabolic processes. The compound engages in specific hydrophobic interactions with receptor sites, facilitating conformational changes that modulate neurotransmitter release. Additionally, its distinct isotopic composition may affect its solubility and diffusion rates in biological systems. | ||||||